Dany Perner
Frankfurt Am Main, HE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Investigation of NS3 Protease Resistance-Associated Variants and Phenotypes for the Prediction of Treatment Response to HCV Triple Therapy.
Journal: PloS one
Published: February 22, 2016
IL28B gene variants and glucose metabolism in Type 2 Diabetes.
Journal: Human immunology
Published: December 15, 2015
Clinical value of on-treatment HCV RNA levels during different sofosbuvir-based antiviral regimens.
Journal: Journal of hepatology
Published: July 13, 2015
Comparison of three quantitative HCV RNA assays in samples from HCV genotype 1- or 4-infected patients treated with the NS3/4A protease inhibitor simeprevir.
Journal: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology
Published: June 03, 2015
Interferon lambda 4 genotypes and resistance-associated variants in patients infected with hepatitis C virus genotypes 1 and 3.
Journal: Hepatology (Baltimore, Md.)
Published: April 16, 2015
Consideration of Viral Resistance for Optimization of Direct Antiviral Therapy of Hepatitis C Virus Genotype 1-Infected Patients.
Journal: PloS one
Published: April 02, 2015
Modulation of replication efficacy of the hepatitis C virus replicon Con1 by site-directed mutagenesis of an NS4B aminoterminal basic leucine zipper.
Journal: Journal of viral hepatitis
Published: October 10, 2012
Serum microRNA-122 kinetics in patients with chronic hepatitis C virus infection during antiviral therapy.
Journal: Journal of viral hepatitis
Published: September 01, 2012
Clinical utility of the ARCHITECT HCV Ag assay for early treatment monitoring in patients with chronic hepatitis C genotype 1 infection.
Journal: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology
Published: February 10, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026